Stocks Ended Lower Yesterday, Bank Fears Weighed, While Investors Cheered Better Than Expected PPI

In 1918, this "miracle medicine" was in every household in America.

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

AN OXFORD CLUB PUBLICATION

We have a message from Karen Reddel at Logical Health Alternatives. Long-time readers of Wealthy Retirement know that we don't often cover healthcare in our content. It's just not our specialty. That's why we wanted to share a thought-provoking message that Karen recently relayed to her readers. - Rachel Gearhart, Associate Publisher Kills More Cancer Cells Than a Dose of Radiation Dear Reader, In 1918, this "miracle medicine" was in every household in America. Valuable enough to get caught in the crossfire during both World Wars... And powerful enough to be studied by the founding members of a massive Big Pharma dynasty... There was nothing else like it on Earth. In fact, this miracle medicine was on track to become a game-changer for fighting the cancer epidemic. But then it just... disappeared. To this day, it's not being taught in medical schools—or prescribed in major U.S. cancer centers. But the results of lab studies are impressive. Big Pharma knows more about this than they're letting on... and these newly discovered documents prove it... Everything you need to know is right here. To your health, Karen Reddel Logical Health Alternatives P.S. No one's talking about this—but this discovery is already changing the lives of cancer patients. See it here before corporate interests make it "disappear" again. You are receiving this email because you subscribed to Wealthy Retirement. Wealthy Retirement is published by The Oxford Club. To stop receiving special invitations and offers from Wealthy Retirement, please click here. Please note: This will not impact the fulfillment of your subscription in any way. Questions? Check out our FAQs. Trying to reach us? Contact us here. Please do not reply to this email as it goes to an unmonitored inbox. Privacy Policy | Whitelist Wealthy Retirement © 2023 The Oxford Club, LLC All Rights Reserved The Oxford Club | 105 West Monument Street | Baltimore, MD 21201 North America: 1.800.589.3430 | International: +1.443.353.4334 | Fax: 1.410.329.1923 Oxfordclub.com Your Legal Questions... Answered What is The Oxford Club? The Oxford Club is a financial publisher with a highly rated track record. We deliver unique and well-researched financial and investment ideas to our Members. What do you do? We share our team of experts' industry knowledge and timely insights with our Members so they have the financial literacy and tools needed to build a rich, fulfilling life. We do not provide any personalized financial advice or advocate the purchase or sale of any security or investment for any specific individual. Instead, the information we share is directed toward a larger audience of all subscribed Members. So you'll make me rich? Maybe! But not exactly. Our goal is to provide the research and information required to help you make you rich. Investment markets have inherent risks, and we can't guarantee future profits. Why should I trust you? We offer information based on what we think will provide the most value to our Members. Our business depends on Members' interest in our ideas and satisfaction with their results. We've been around for 30-plus years because our Members have continually chosen to stay with us (many of them for life). We expressly forbid our writers from having a financial interest in their own securities recommendations to readers. All of our employees and agents must wait 24 hours after online publication or 72 hours after the mailing of printed-only publications before following an initial recommendation. So I can fire my investment advisor? No! Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.